FDA NDC Directory · JSON-LD · Markdown

Dantrolene Sodium

NDC 50268-217 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAvPAK
Marketing categoryAbbreviated NDA (generic) · App ANDA076856
Dosage form / routeCAPSULE · ORAL
Active ingredientsDANTROLENE SODIUM (25 mg/1)
Marketing started20210309
Package count1

External sources

Source: openFDA. Public-domain (CC0).